Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04761354




Registration number
NCT04761354
Ethics application status
Date submitted
10/02/2021
Date registered
18/02/2021

Titles & IDs
Public title
Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
Scientific title
Characteristics Predicting Clinically Relevant Reduction of Hypertension Following Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
Secondary ID [1] 0 0
16-196/C
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Primary Aldosteronism Due to Aldosterone Producing Adenoma 0 0
Primary Aldosteronism 0 0
Primary Aldosteronism Due to Conn Adenoma 0 0
Condition category
Condition code
Cancer 0 0 0 0
Bowel - Back passage (rectum) or large bowel (colon)
Metabolic and Endocrine 0 0 0 0
Other endocrine disorders
Cardiovascular 0 0 0 0
Hypertension

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
University Medical Center Utrecht - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Medical Center Groningen - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Vu University Medical Center Amsterdam - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Medical Center Maastricht - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Academic Medical Center Amsterdam - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Istituto di Semeiotica Chirurgica Roma - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of California San Francisco - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Northwestern Memorial Hospital - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Weill Cornell Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Columbia University Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of Chicago Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

M.D. Anderson Cancer Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Boston Medical Center - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University Health Network Toronto - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Montreal General Hospital - McGill University - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

University of Sydney - Patients who underwent adrenalectomy for primary aldosteronism in case of an aldosterone-producing-adenoma

Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Postoperative blood pressure measurement
Assessment method [1] 0 0
systolic and diastolic blood pressure via office blood pressure measurements
Timepoint [1] 0 0
6 months postoperative
Primary outcome [2] 0 0
antihypertensive medication use
Assessment method [2] 0 0
number of antihypertensives in defined daily dose
Timepoint [2] 0 0
6 months postoperative (corresponding to the entered postoperative blood pressure)
Primary outcome [3] 0 0
resolution of hypertension
Assessment method [3] 0 0
resolution of hypertension score via the PASO consensus criteria
Timepoint [3] 0 0
6 months postoperative
Secondary outcome [1] 0 0
Postoperative serum potassium level
Assessment method [1] 0 0
Serum potassium in mmol/l.
Timepoint [1] 0 0
6 months postoperative
Secondary outcome [2] 0 0
Postoperative plasma aldosterone level in lying and standing position
Assessment method [2] 0 0
Plasma aldosterone in nmol/l.
Timepoint [2] 0 0
6 months postoperative
Secondary outcome [3] 0 0
Postoperative plasma renin activity in lying and standing position
Assessment method [3] 0 0
Plasma renin activity in mg/L/u.
Timepoint [3] 0 0
6 months postoperative
Secondary outcome [4] 0 0
Postoperative aldosterone to renin ratio
Assessment method [4] 0 0
Aldosterone to renin ratio using plasma aldosterone level and plasma renin activity
Timepoint [4] 0 0
6 months postoperative
Secondary outcome [5] 0 0
Postoperative plasma creatinine level
Assessment method [5] 0 0
Plasma creatinine in mg/dL
Timepoint [5] 0 0
6 months postoperative
Secondary outcome [6] 0 0
Pathology
Assessment method [6] 0 0
Final result of pathology after adrenalectomy
Timepoint [6] 0 0
6 months postoperative

Eligibility
Key inclusion criteria
* All patients who underwent unilateral adrenalectomy between 2010 and 2016 for APA.
* Patients with biochemical evidence of primary aldosteronism who underwent adrenalectomy on account of an aldosterone-producing adenoma(APA), proven by Computerized Tomography(CT) or Magnetic Resonance Imaging(MRI) or Adrenal Venous Sampling(AVS).
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Age <18 years.
* Missing or incomplete data about preoperative blood pressure and number of antihypertensive drugs.
* Missing or incomplete follow-up data about postoperative blood pressure and number of antihypertensive drugs. We aim enter the blood pressure and number of antihypertensive drugs closest to 6 months after adrenalectomy.

Study design
Purpose
Duration
Selection
Timing
Retrospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
University of Sydney - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Illinois
Country [3] 0 0
United States of America
State/province [3] 0 0
Massachusetts
Country [4] 0 0
United States of America
State/province [4] 0 0
New York
Country [5] 0 0
United States of America
State/province [5] 0 0
Texas
Country [6] 0 0
Canada
State/province [6] 0 0
Ontario
Country [7] 0 0
Canada
State/province [7] 0 0
Quebec
Country [8] 0 0
Italy
State/province [8] 0 0
Lazio
Country [9] 0 0
Netherlands
State/province [9] 0 0
Limburg
Country [10] 0 0
Netherlands
State/province [10] 0 0
Noord-Holland
Country [11] 0 0
Netherlands
State/province [11] 0 0
Groningen

Funding & Sponsors
Primary sponsor type
Other
Name
UMC Utrecht
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
University of California, San Francisco
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Northwestern Memorial Hospital
Country [2] 0 0
Other collaborator category [3] 0 0
Other
Name [3] 0 0
Weill Medical College of Cornell University
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
Columbia University
Country [4] 0 0
Other collaborator category [5] 0 0
Other
Name [5] 0 0
University of Chicago
Country [5] 0 0
Other collaborator category [6] 0 0
Other
Name [6] 0 0
M.D. Anderson Cancer Center
Country [6] 0 0
Other collaborator category [7] 0 0
Other
Name [7] 0 0
Boston Medical Center
Country [7] 0 0
Other collaborator category [8] 0 0
Other
Name [8] 0 0
University Health Network, Toronto
Country [8] 0 0
Other collaborator category [9] 0 0
Other
Name [9] 0 0
Montreal General Hospital
Country [9] 0 0
Other collaborator category [10] 0 0
Other
Name [10] 0 0
University of Sydney
Country [10] 0 0
Other collaborator category [11] 0 0
Other
Name [11] 0 0
University Medical Center Groningen
Country [11] 0 0
Other collaborator category [12] 0 0
Other
Name [12] 0 0
Maastricht University Medical Center
Country [12] 0 0
Other collaborator category [13] 0 0
Other
Name [13] 0 0
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Country [13] 0 0
Other collaborator category [14] 0 0
Other
Name [14] 0 0
Catholic University of the Sacred Heart
Country [14] 0 0
Other collaborator category [15] 0 0
Other
Name [15] 0 0
Amsterdam UMC, location VUmc
Country [15] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Menno R Vriens, MD
Address 0 0
UMC Utrecht
Country 0 0
Phone 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

Results publications and other study-related documents